Clinical Commander

All dossiers
cardio.cardiac-tamponade.myxedema-effusion.v1

Cardiac tamponade — myxedema-related pericardial effusion

cardiologyacuteadultacuteinpatienttransitionoutpatient
Start encounter →Print handoutPRODUCTION

Phase E variant of cardio.cardiac-tamponade.core.v1 — narrowed to myxedema-related pericardial effusion in severe untreated hypothyroidism (TSH typically >50 mIU/L, free T4 markedly low). Pathophysiology: mucopolysaccharide accumulation in pericardium with capillary permeability changes leading to chronic large effusion. KEY CLINICAL FEATURE: tamponade is RARE despite effusion often being massive (>2 cm, occasionally 1-2 L) because slow accumulation allows pericardial stretch (Spodick compliance curve). When tamponade present, suspect acute decompensation, concurrent pericarditis from another etiology, or sustained accumulation reaching pericardial limit. Concurrent cardiac dysfunction is the rule: bradycardia (40-60), prolonged QT (torsades risk), low cardiac output, decreased contractility (Klein NEJM 2007 PMID 17314344). Demographic: severe untreated hypothyroidism — elderly women, post-thyroidectomy/RAI lost to follow-up, autoimmune Hashimoto, iodine deficiency, infiltrative thyroid disease. Inherits drainage + bridge regimen from parent via routing; specializes for thyroid-axis labs (TSH + free T4 + free T3 + TPO antibodies) + cortisol/ACTH BEFORE empiric hydrocortisone (5-10% concurrent autoimmune AI in Schmidt syndrome per Wartofsky); levothyroxine LOAD 200-500 µg IV (200 elderly/CV; 500 young+healthy) + maintenance 50-100 µg IV daily (transition to PO once stable, 1.6 µg/kg PO daily target, dose-adjusted for cardiovascular disease per ATA 2014 PMID 25266247); CONCURRENT hydrocortisone 100 mg IV q8h until cosyntropin negative (MUST precede full thyroid replacement to avoid AI crisis from increased cortisol metabolism per Wartofsky); pericardiocentesis ONLY if true tamponade physiology (rare); supportive care: passive rewarming for hypothermia, cautious NS for hypotension (avoid free water for hyponatremia), correct electrolytes, ventilatory support if hypoventilation/coma. AVOID rapid normothyroid (Wernicke-like myxedema decompensation), AVOID over-aggressive diuresis (worsens hyponatremia), AVOID sedation/opioids (decreased clearance). Severity triggers cover myxedema coma overlap, concurrent adrenal insufficiency (Schmidt syndrome), levothyroxine-induced arrhythmia/ischemia, and hyponatremia worsening with aggressive fluid management. Long-term thyroid hormone replacement + cardiac surveillance for residual cardiomyopathy. Effusion resolution often takes months even with adequate replacement. Manifest pointer reuses cardio.cardiac-tamponade.core.v1 manifest. Design-brief pointer reuses parent (myxedema-specific differences documented inline). Status INTEGRATED until terminology + RxNav-validated drug codes are reconciled. Authored 2026-05-15 by shard-06-cardio-acute.

Entry points (5)

  • symptom
    Severe hypothyroid features (cold intolerance, weight gain, lethargy, constipation, hoarse voice, periorbital edema, dry skin, bradycardia) + dyspnea + JVD → consider myxedema effusion (Klein NEJM 2007 PMID 17314344)
    severe_hypothyroid_features_with_dyspnea
  • imaging
    Echo: large pericardial effusion (often >2 cm, occasionally 1-2 L) without tamponade physiology in patient with myxedema features — chronic accumulation allows pericardial stretch (Spodick compliance curve)
    echo_massive_chronic_effusion_without_tamponade
  • history
    Known hypothyroidism off levothyroxine for months/years OR post-thyroidectomy/RAI lost to follow-up + pericardial effusion (ATA 2014 PMID 25266247)
    untreated_hypothyroidism_or_lost_levothyroxine_with_pericardial_effusion
  • symptom
    Myxedema coma (altered mental status, hypothermia, bradycardia, hypoventilation) + pericardial effusion → critical care emergency with thyroid + adrenal coverage (Wartofsky)
    myxedema_coma_with_pericardial_disease
  • imaging
    Low-voltage ECG + bradycardia + prolonged QT in hypothyroid patient → consider pericardial effusion as voltage-attenuating cause + concurrent hypothyroid cardiomyopathy (Klein NEJM 2007 PMID 17314344)
    low_voltage_ecg_with_bradycardia_in_hypothyroid_pt

Required inputs (10)

  • agerequired
    demographic • used at CONTEXT
    Older patients more vulnerable to cardiovascular ischemia from rapid levothyroxine — drives load-strategy decision per ATA 2014
  • sbprequired
    vital • used at RED_FLAGS
    Hypotension may reflect myxedema coma, concurrent adrenal insufficiency, or true tamponade — context-dependent interpretation (Wartofsky)
  • hrrequired
    vital • used at RED_FLAGS
    Bradycardia (40-60 bpm) is hallmark of severe hypothyroidism — ABSENCE of compensatory tachycardia in tamponade is a key clue masking severity (Klein NEJM 2007)
  • temperaturerequired
    vital • used at RED_FLAGS
    Hypothermia (often <35°C) is hallmark of myxedema coma; mortality risk marker (Wartofsky)
  • echorequired
    imaging • used at INITIAL_WORKUP
    Definitive bedside dx — characterize effusion size + tamponade physiology (often ABSENT despite massive effusion); LV wall motion + EF for hypothyroid cardiomyopathy assessment (ESC 2015; Klein NEJM 2007)
  • tsh_and_free_t4required
    lab • used at INITIAL_WORKUP
    TSH typically >50 (often >100); free T4 markedly low (<0.5 ng/dL); confirms severe hypothyroidism etiology (ATA 2014 PMID 25266247)
  • cortisol_and_acthrequired
    lab • used at INITIAL_WORKUP
    Random cortisol + ACTH BEFORE hydrocortisone empirical dose to evaluate concurrent adrenal insufficiency (5-10% concurrent in myxedema per Wartofsky); cosyntropin stimulation if borderline; pituitary disease consideration if ACTH inappropriately low
  • sodiumrequired
    lab • used at INITIAL_WORKUP
    Hyponatremia common in severe hypothyroidism (SIADH-like via decreased free water clearance); guides cautious fluid management — NS rather than free water; AVOID over-correction risk of osmotic demyelination (Wartofsky)
  • glucoserequired
    lab • used at INITIAL_WORKUP
    Hypoglycemia common in concurrent adrenal insufficiency or severe hypothyroidism with poor intake (Wartofsky)
  • ecg_with_qt_assessmentrequired
    imaging • used at INITIAL_WORKUP
    Low voltage + bradycardia + prolonged QT (torsades risk) define cardiac severity; QT prolongation guides electrolyte management + medication choices (Klein NEJM 2007)

12-phase flow (8)

  1. 1FRAME
    Myxedema effusion is typically CHRONIC + MASSIVE without tamponade physiology (slow accumulation allows pericardial stretch); when tamponade present, suspect acute decompensation/concurrent pericarditis; levothyroxine + hydrocortisone are foundational; pericardiocentesis ONLY for true tamponade (Klein NEJM 2007; Wartofsky)
    inputs: hr
    advance: myxedema-context effusion confirmed
  2. 2ENTRY
    Recognize severe hypothyroidism features + assess for myxedema coma overlap (altered mental status + hypothermia + hypoventilation) (Wartofsky)
    inputs: age, temperature
    advance: myxedema severity stratified
  3. 3CONTEXT
    Hypothyroidism etiology + prior treatment + adherence + concurrent autoimmune disease history (Hashimoto, Schmidt syndrome with adrenal involvement); precipitating factors (infection, cold exposure, sedation, surgery) (Wartofsky)
    advance: hypothyroidism context captured
  4. 4RED_FLAGS
    True tamponade physiology (rare) + myxedema coma + concurrent adrenal insufficiency + hyponatremia + hypothermia + hypoglycemia + hypoventilation (Wartofsky)
    inputs: sbp, hr, temperature
    actions: cardiac_tamponade
    advance: critical features stratified
  5. 5INITIAL_WORKUP
    STAT echo, ECG, CXR, troponin, BMP, CBC, TSH + free T4 + free T3, cortisol + ACTH (BEFORE empiric hydrocortisone), TPO antibodies, BUN, glucose, lactate, ABG (CO2 retention common) (ATA 2014; Wartofsky; Klein NEJM 2007)
    inputs: echo, tsh_and_free_t4, cortisol_and_acth, sodium, glucose, ecg_with_qt_assessment
    actions: panel.cardiac, panel.renal, panel.abg
    advance: echo + thyroid + adrenal + electrolyte + acid-base assessment complete
  6. 6TREATMENT
    Step 1 echo-guided pericardiocentesis ONLY if true tamponade physiology (rare); Step 2 levothyroxine LOAD 200-500 µg IV (200 in elderly/CV disease, 500 if young + healthy); Step 3 levothyroxine maintenance 50-100 µg IV daily until PO tolerated; Step 4 CONCURRENT hydrocortisone 100 mg IV q8h until adrenal insufficiency excluded (cosyntropin) — adrenal coverage MUST precede full levothyroxine (otherwise adrenal crisis from increased cortisol metabolism); Step 5 supportive: passive rewarming for hypothermia, cautious NS for hypotension (avoid free water for hyponatremia), correct electrolytes; Step 6 ventilatory support if hypoventilation/coma; Step 7 treat precipitating cause (infection, etc.) (Wartofsky; ATA 2014; Klein NEJM 2007)
    inputs: sbp
    advance: levothyroxine loaded + hydrocortisone covered + supportive measures + pericardial drainage if true tamponade
  7. 7DISPOSITION
    CCU/ICU if myxedema coma or true tamponade; endocrinology + cardiology + critical care multidisciplinary; passive rewarming + supportive care (Wartofsky)
    advance: multidisciplinary disposition confirmed
  8. 8MONITORING
    TSH + free T4 trend (response over weeks not hours); cortisol axis re-evaluation once euthyroid; effusion resolution trajectory (often months); ECG for QT + bradycardia; cardiac function recovery; AVOID over-aggressive levothyroxine titration risk of arrhythmia + ischemia (ATA 2014)
    actions: panel.cardiac
    advance: thyroid replacement established + cardiac surveillance ongoing